Literature DB >> 16963396

The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma.

Rony M Abou-Jawde1, Rachid Baz, Esteban Walker, Toni K Choueiri, Mary Ann Karam, Janice Reed, Beth Faiman, Mohamad Hussein.   

Abstract

The incidence and mortality of multiple myeloma (MM) in African-Americans is double that in whites. We questioned whether race, socioeconomic status, and distance traveled affect overall survival. In a retrospective review of the records of 292 patients with MM. We found that the median age was 60 years and 38 patients were African-Americans. The mean distance traveled was 67.7 miles. The median overall survival was similar in African-Americans and whites. Race, distance traveled and socioeconomic status were not independent prognostic factors for overall survival. In conclusion, socioeconomic status, distance traveled and race did not affect outcomes of MM patients treated at a specialized myeloma center.

Entities:  

Mesh:

Year:  2006        PMID: 16963396

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  12 in total

1.  Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity.

Authors:  Maira A Castañeda-Avila; Bill M Jesdale; Ariel Beccia; Ganga S Bey; Mara M Epstein
Journal:  Cancer Causes Control       Date:  2021-06-05       Impact factor: 2.506

2.  Racial differences in primary central nervous system lymphoma incidence and survival rates.

Authors:  Jose S Pulido; Robert A Vierkant; Janet E Olson; Lauren Abrey; David Schiff; Brian Patrick O'Neill
Journal:  Neuro Oncol       Date:  2009-03-09       Impact factor: 12.300

Review 3.  Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?

Authors:  Sikander Ailawadhi; Kirtipal Bhatia; Sonikpreet Aulakh; Zahara Meghji; Asher Chanan-Khan
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

4.  Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Nandita Khera; Ted Gooley; Mary E D Flowers; Brenda M Sandmaier; Fausto Loberiza; Stephanie J Lee; Frederick Appelbaum
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-22       Impact factor: 5.742

5.  Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials.

Authors:  James E Herndon; Alice B Kornblith; Jimmie C Holland; Electra D Paskett
Journal:  Psychooncology       Date:  2011-10-20       Impact factor: 3.894

6.  Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Authors:  Adam J Waxman; Pamela J Mink; Susan S Devesa; William F Anderson; Brendan M Weiss; Sigurdur Y Kristinsson; Katherine A McGlynn; Ola Landgren
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

7.  Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.

Authors:  Mark A Fiala; Joseph D Finney; Jingxia Liu; Keith E Stockerl-Goldstein; Michael H Tomasson; Ravi Vij; Tanya M Wildes
Journal:  Leuk Lymphoma       Date:  2015-03-08

8.  Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

Authors:  Parameswaran N Hari; Navneet S Majhail; Mei-Jie Zhang; Anna Hassebroek; Fareeha Siddiqui; Karen Ballen; Asad Bashey; Jenny Bird; Cesar O Freytes; John Gibson; Gregaory Hale; Leona Holmberg; Ram Kamble; Robert A Kyle; Hillard M Lazarus; Charles F LeMaistre; Fausto Loberiza; Angelo Maiolino; Philip L McCarthy; Gustavo Milone; Nancy Omondi; Donna E Reece; Matthew Seftel; Michael Trigg; David Vesole; Brendan Weiss; Peter Wiernik; Stephanie J Lee; J Douglas Rizzo; Paulette Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-14       Impact factor: 5.742

9.  Patient education level as a predictor of survival in lung cancer clinical trials.

Authors:  James E Herndon; Alice B Kornblith; Jimmie C Holland; Electra D Paskett
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

10.  Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sigurdur Y Kristinsson; Thomas R Fears; Gloria Gridley; Ingemar Turesson; Ulf-Henrik Mellqvist; Magnus Björkholm; Ola Landgren
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.